In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…
Tweet Zanghì A, Spelman T, Fabis-Pedrini M, Carroll WM, Butzkueven H, Kermode AG, Lechner-Scott J, van der Walt A, D’Amico E. Ocrelizumab Discontinuation vs. Continuation After Safety Events: Comparative Insights from MSBase. Curr Neuropharmacol. 2026 Mar 24. doi: 10.2174/011570159X448901251228053318. Introduction: Ocrelizumab (OCR), a CD20+ B-cell…